A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer - Concepedia

Concepedia

Publication | Closed Access

A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer

19

Citations

55

References

2024

Year

Kejing Zhang, Juan Wei, She-Yu Zhang, Liyan Fei, Lu Guo, Xueying Liu, YiShuai Ji, Wenjun Chen, Felipe E. Ciamponi, Weichang Chen,

Cell chemical biology

Tumor BiologyBreast OncologyMedicinePharmacologyCancer BiologyBreast CancerChemical ScreenTherapeutic VulnerabilityCancer TreatmentAnti-cancer AgentOncologyCell BiologyCancer Research

References

	Year	Citations

Page 1

Page 1